Showing results (51-60 of 334) with videos related to
Sort By:
Pageof 34
Analytical Biochemistry|September 5, 1996
A novel method for chemical modification of functional groups other than a carboxyl group in proteins by N-ethyl-5-phenylisooxazolium-3'-sulfonate (Woodward's reagent-K): inhibition of ADP-induced platelet responses involves covalent modification of aggregin, an ADP receptorR N Puri, R W ColmanBlood|December 1, 1980
Crotalocytin: characterization of the timber rattlesnake platelet activating proteinA H Schmaier, R W ColmanEuropean Journal of Biochemistry|October 17, 1983
Inhibition of ADP-induced platelet aggregation by reduced factor XaA K Sinha, R W ColmanThrombosis Research|June 15, 1983
Cyclic AMP independent inhibition of platelet aggregation by prostaglandin E1 is mediated through factor XaA K Sinha, R W ColmanThe Journal of Clinical Investigation|February 1, 1980
Function and immunochemistry of prekallikrein-high molecular weight kininogen complex in plasmaC F Scott, R W ColmanArchives of Biochemistry and Biophysics|May 1, 1991
Inhibition of ADP-induced platelet shape change and aggregation by o-phthalaldehyde: evidence for covalent modification of cysteine and lysine residuesR N Puri, R W ColmanThe Journal of Biological Chemistry|May 5, 1991
Localization of distinct functional domains on prekallikrein for interaction with both high molecular weight kininogen and activated factor XII in a 28-kDa fragment (amino acids 141-371)J D Page, R W ColmanProtein Science : a Publication of the Protein Society|January 1, 1992
The sequence HGLGHGHEQQHGLGHGH in the light chain of high molecular weight kininogen serves as a primary structural feature for zinc-dependent binding to an anionic surfaceR A DeLa Cadena, R W ColmanAmerican Journal of Clinical Pathology|July 1, 1975
Statistical comparison of the fibrometer and the Electra 600 for prothrombin time determinationR W Colman, G Williams, J WyllieMolecular Pharmacology|August 16, 2002
Identification of interaction sites of cyclic nucleotide phosphodiesterase type 3A with milrinone and cilostazol using molecular modeling and site-directed mutagenesisW Zhang, H Ke, R W ColmanPageof 34